Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05810896 · ClinicalTrials.gov registry record · NA
AF at Home: A Virtual Education Program for Patients With Atrial Fibrillation (AF)
A NA study of Atrial Fibrillation, sponsored by University of North Carolina, Chapel Hill.
- Active
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT05810896: Active NA study of Atrial Fibrillation, sponsored by University of North Carolina, Chapel Hill.
NCT05810896 is a NA study of Atrial Fibrillation that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 300 participants, below the 2,995-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05810896, a NA study of Atrial Fibrillation, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this study is to determine the effectiveness of a direct-to-patient virtual education program ("AF at Home") for adults with atrial fibrillation (AF). The main questions this study aims to answer are: 1. Will participants in the educational program have improvement in quality of life, self-monitoring, and self-management strategies after program completion? 2. Will patient level quality of AF care improve for participants in the educational program? Participants will be asked to: * Participate in six hours of virtual education sessions over three weeks via Zoom. * Complete online questionnaires before the program starts and after its completion.
Primary Outcome
The AFEQT questionnaire is a validated tool used to measure self-reported quality of life specifically for patients with atrial fibrillation. The questionnaire includes 20 questions measured on a 7-point Likert scale (1= not at all to 7=extremely) with 3 subcategories. The subcategories include symptoms (questions 1-4), daily activities (questions 5-12), and treatment concerns (questions 13-18). Scoring provides an overall AFEQT score (based on questions 1-18), and a treatment satisfaction score
Conditions Studied
Interventions
- OTHER AF at Home
Study Locations (3)
North Carolina
- University of North Carolina, Chapel Hill - Chapel Hill
- Duke University - Durham
- Wake Forest University - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-04-12 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT05810896 still lists
NCT05810896 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 2,995-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which AF at Home is the first listed.
NCT05810896 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05810896 about?
NCT05810896 is a clinical study titled "AF at Home: A Virtual Education Program for Patients With Atrial Fibrillation (AF)". The goal of this study is to determine the effectiveness of a direct-to-patient virtual education program ("AF at Home") for adults with atrial fibrillation (AF). The main questions this study aims to answer are: 1. Will participants in the educational program have improvement in quality of life, s...
What is the current status of trial NCT05810896?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-04-12. Estimated completion is 2026-06.
What conditions does trial NCT05810896 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT05810896?
The interventions under investigation include: AF at Home (OTHER).
Who is sponsoring clinical trial NCT05810896?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05810896 being conducted?
This trial has 3 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05810896's enrollment target sits among peer trials
300 83rd of 202 higher than 120 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI